Purchase Order 75N93022P00869

Award Date 7/25/22
Potential Completion Date 7/24/27
Potential Value $399K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20052, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $35,910 firm-fixed-price purchase order to George Washington University (GWU) to procure graduate student tuition assistance for the third year of the NIH Graduate Partnerships Program (GPP). The contract does not have a set-aside designation. This sole-source contract was awarded under the statutory authority of 41 U.S.C. 1901(a)(1) as implemented by FAR 13.106-1, as NIAID...
The University of Georgia Research Foundation, Inc. was awarded a $2,179,128 firm-fixed-price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract calls for the production of 110,000 Brugia malayi infective larvae or adult worms annually to support research on host-parasite interactions and immune responses, as described in the statement of work. There is no set-aside designation. Delivery...
This is a firm fixed-price $4,560 purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to The George Washington University Student Accounts Office / Third Party Division. The contract does not have a set-aside designation. The contract was awarded on September 7, 2012 with a completion date of September 30, 2012. The George Washington University Student Accounts Office / Third Party Division has a history...
This federal contract award, valued at $1,428,793.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government. The contract is for the provision of medical residents to support the National Institutes of Health's (NIH) Clinical Center. The prime contractor for this delivery order contract is George Washington University, a private research university located in Washington, D.C. The contract is a firm fixed-price agreement...
The George Washington University (GWU) was awarded a firm fixed price delivery order against the Resident Services Contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. With a potential value of $2,575,568.45 and a completion date of October 31, 2024, this contract calls for GWU to provide resident services to NIAID in Bethesda, Maryland through October 31, 2020. As the prime contractor, GWU will utilize its Student Accounts Office and Third Party...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to the University of Georgia Research Foundation, Inc. (UGA Research Foundation) for the Production of B. malayi Infective Larvae and Adult Worms. The contract has a potential value of $1,673,129.00 and a completion date of August 31, 2022. UGA Research Foundation is a non-profit organization that manages sponsored programs...
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The George Washington University's Student Accounts Office / Third Party Division. The contract, valued at $306,866.00, is for the provision of medical resident services for the NIAID's Clinical Center. The contract does not have a set-aside designation and has a performance period through May 30, 2025. The George Washington University has...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $429,000.00 firm-fixed price purchase order to the Biomedical Research Institute (BRI), a non-profit organization, for the maintenance of the Schistosoma mansoni parasite lifecycle and the delivery of Schistosoma eggs to support research on schistosomiasis, a prevalent disease in the developing world. This sole-source award, which is not set aside, will run for a base...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Georgetown University. The contract is a delivery order under the NIAID Animal Models of Infectious Diseases 2010-2017 contract vehicle, which is a cost-no-fee contract. Georgetown University, a private non-profit university, is the prime contractor. The contract has a ceiling value of $5,746,219.71 and was awarded on March 22, 2010...
The National Institute of Allergy and Infectious Diseases awarded a $1.3 million base contract to the University of Georgia Research Foundation, Inc. to provide production and distribution of filarial research reagents in support of the NIAID Preclinical Models of Infectious Diseases 2017-2024 master IDIQ. The contract has a potential value of $3,961,574 and a period of performance through February 2025. There is no set-aside designation. As the prime contractor, the University of Georgia...

This is a sole source contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to George Washington University for the production of Good Manufacturing Practice (cGMP) grade Trichuris trichiura nematodes. The contract has a ceiling value of $398,537.00 and a period of performance consisting of a base year plus four one-year option periods. The nematodes will be used by NIAID's Laboratory of Parasitic Diseases for a Controlled Human Trichuris Infection trial. George Washington University is the only known vendor capable of meeting the cGMP and research reproducibility requirements for this effort. The contract is not set-aside and utilizes a firm-fixed price type. It is part of NIAID's ongoing work to develop treatments and countermeasures for infectious diseases.

Generated 6/24/25, 10:07 AM